Detection of EGFR Mutations in cfDNA and CTCs, and Comparison to Tumor Tissue in Non-Small-Cell-Lung-Cancer (NSCLC) Patients

Lung cancer is the leading cause of cancer-related mortality worldwide. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapies, based on the evaluation of EGFR mutations, have shown dramatic clinical benefits. EGFR mutation assays are mainly performed on tumor biopsies, wh...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Liu, Haiyan E., Vuppalapaty, Meghah, Wilkerson, Charles, Renier, Corinne, Chiu, Michael, Lemaire, Clementine, Che, James, Matsumoto, Melissa, Carroll, James, Crouse, Steve, Hanft, Violet R., Jeffrey, Stefanie S., Di Carlo, Dino, Garon, Edward B., Goldman, Jonathan, Sollier, Elodie
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7578230/
https://ncbi.nlm.nih.gov/pubmed/33117705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.572895
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia